British government administers deadly drug to elderly patients in nursing homes

BY MICHAEL THOMAS

What if the world were told that the end-of-life drug Midazolam was used to eliminate the elderly in long term care homes, then tell the family and the world that they died of so called COVID-19?

Strong evidence points to this exact crime, and even the persons that gave these orders, as well as those who carried the orders out.

In the early stages of this so-called pandemic there was a mass number of deaths primarily of senior citizens who lived in old age homes. These deaths were often categorized as pandemic-related, but as independent thinkers and investigative journalists started looking closer, they found out that they were not being told the full story.

The World Health Organization (WHO) said, “Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment.” However, they state “Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.”

The public was also told of the deadly symptoms, which can accompany this disease like pneumonia and accompanying respiratory insufficiency. Typical symptoms include breathlessness, cough, weakness and fever.

What the public was not told was that the British government had ordered two years’ worth of Midazolam, a drug with side effects almost identical to the so-called COVID symptoms and gave the order to administer this deadly drug to elderly patients in the nursing homes.

Doctors and caregivers were not allowed to admit these elderly people to hospitals no matter how sick they became. This order came from Matt Hancock, Secretary of State For Health and Social Care in Britain.

It was observed than once this medication was in effect in the nursing homes so was the deaths for that particular period. It is well known in medical circles that Midazolam induces significant depression of respiration.

Knowing that, would any doctor or nurse use Midazolam to treat people who were suffering with pneumonia and respiratory insufficiency due to COVID-19?

Did the public miss something here? Long before this so-called pandemic a policy has been in place, which clearly states that Midazolam can be used for sedation. However, the dosage should be reduced to 0.5mg in the elderly or sick due to possible side effects, which include cardio-respiratory depression, and extreme caution should be used in administering Midazolam to patients suffering respiratory disease.

Apparently, a policy was created for treating patients suffering anxiety due to what the public was told is COVID-19. It clearly states to treat the patient with a starting dose of 2.5mg of Midazolam, or 1.25mg if the patient is “particularly frail.” Medical professionals were to bump this up to 5-10mg if the patient was “extremely distressed”. This deliberately goes against medical rules, and as a result here is what happened:

• The spikes in production of Midazolam solution match the spikes of alleged COVID deaths within twenty-eight days of a positive test
• April 2020 – huge surge in Midazolam prescriptions out of hospital and huge surge in production of Midazolam solution
• April 2020 – huge surge in alleged COVID deaths.
• January 2021 – huge surge in production of Midazolam solution
• January 2021 – huge surge in alleged COVID deaths

The stay-at-home orders combined with no hospital visitors was why these orders were deployed with little intervention.

Imagine being elderly, placed in a nursing home, or hospital, and have a DNR “Do not resuscitate” order put on you without the consent of you or your family. Just think of that. This all happened while the world was and still is in some parts under “locked-down.”

More and more studies are coming out on how terribly this pandemic was handled. It is unfortunate that so many of us have lost our loved ones.